Treatment of Mpox with Suspected Tecovirimat Resistance in Immunocompromised Patient, United States, 2022.
Contag CA, Mische L, Fong I, Karan A, Vaidya A, McCormick DW, Bower W, Hacker JK, Johnson K, SanJuan P, Crebbin L, Temmins C, Sahni H, Bogler Y, Cooper JD, Narasimhan S.
Contag CA, et al. Among authors: sahni h.
Emerg Infect Dis. 2023 Dec;29(12):2520-2523. doi: 10.3201/eid2912.230849. Epub 2023 Oct 19.
Emerg Infect Dis. 2023.
PMID: 37856215
Free PMC article.